QMS Medical Allied Services Ltd is targeting consolidated revenue of over Rs. 500 crore by FY29 following its migration to the Mainboard platform of the National Stock Exchange (NSE).

The integrated healthcare solutions company's 1.93 crore equity shares became tradable on the NSE Mainboard on June 18 after migrating from the NSE Emerge platform, where it was listed in October 2022.

"Our listing on NSE Mainboard is a defining milestone in QMS's evolution and reflects the strong foundation we have built over the years. We are now setting sights on tripling our revenues in the next three years," Chairman and Managing Director Mahesh Makhija said.

"Our sustained efforts to deepen and scale our presence across both product and service verticals now give us an edge to thrive in a high-demand, rapidly evolving market with global potential," he added.

QMS Medical reported consolidated revenue of Rs. 172.9 crore and EBITDA of Rs 25.9 crore in FY26. 

The company derives revenue from both healthcare products and services, including patient service programmes, disease management initiatives, patient screening camps, medical and diagnostic solutions, and healthcare staffing services.